MB Group n = 311 | Non-MB Group n = 202 | p-value | |
---|---|---|---|
Age [years] | 65.7 ± 12.0 | 65.8 ± 11.4 | n.s. |
Male | 243 [78] | 163 [81] | n.s. |
BMI [kg/m2] | 31.7 ± 57.8 | 27.7 ± 6.5 | n.s. |
ASA | |||
1–2 | 5 [2] | 8 [4] | 0.001 |
3 | 136 [46] | 122 [60] | |
4 | 138 [47] | 67 [33] | |
5 | 12 [4] | 1 [1] | |
Nicotine Abuse | 94 [32] | 71 [35] | n.s. |
Coronary Heart Disease | 191 [65] | 144 [71] | n.s. |
With Stent | 22 [7] | 11 [5] | n.s. |
Angina Pectoris | 67 [23] | 79 [39] | 0.001 |
Previous Myocardial Infarction | 81 [27] | 35 [17] | 0.009 |
NYHA | |||
1 | 1 [0.3] | 0 | 0.014 |
2 | 15 [5] | 7 [4] | |
3 | 162 [56] | 143 [71] | |
4 | 106 [36] | 47 [23] | |
Left Ventricular Ejection Fraction [%] | 47.5 ± 18.8 | 45.8 ± 17. | n.s. |
Pacemaker | 23 [8] | 13 [6] | n.s. |
Hypertension | 203 [69] | 147 [75] | n.s. |
Peripheral Arterial Disease | 47 [16] | 36 [18] | n.s. |
With Stent | 25 [8] | 17 [8] | n.s. |
Pulmonary Hypertension | 30 [10] | 16 [8] | n.s. |
Renal Failure | |||
GFR > 89 mL/min | 35 [11] | 42 [21] | 0.004 |
GFR 60–89 | 64 [21] | 58 [29] | |
GFR 30–59 | 59 [19] | 38 [19] | |
GFR < 30 | 29 [9] | 9 [5] | |
Dialysis | 1 [0.3] | 0 | |
Cerebrovascular Events | 20 [7] | 6 [3] | n.s. |
Allergy | 54 [18] | 39 [19] | n.s. |